Its old news. The product isn't underdosed it was just an inefficient recovery of the epistane hormone by the lab. All of the methylepitiostanol products came out low, in fact, epistane was the highest of the lows.
But again, it wasn't a problem with the product(s), its just that the labs couldn't figure out how to yield a high recovery of epistane when separating it from the fillers.